Related Experiment Video
Updated: Aug 24, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Construction and transfection of a ribozyme targeting human caspase-3
Deirdre Cronin1, Carmel Daly, Toni O'Doherty
1National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
Abstract:
Caspase-3 is a key executioner cysteine protease involved in programmed cell death or apoptosis. A ribozyme to human caspase-3 was designed, tested by in vitro cleavage, and transfected into a drug-resistant variant (DLKP-A5F) of a human lung carcinoma cell line (DLKP). By both stable and transient transfection, this ribozyme was shown to be effective at down-regulating human caspase-3 mRNA and protein levels.
Insights
Researchers designed a ribozyme to target human caspase-3, a protein crucial for apoptosis. This ribozyme effectively reduced caspase-3 mRNA and protein in lung cancer cells, demonstrating its potential for gene regulation.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Caspase-3 is a critical enzyme in apoptosis (programmed cell death).
- Targeting caspase-3 is a potential strategy for cancer therapy.
- Drug-resistant cancer cell lines present a challenge in treatment.
Purpose of the Study:
- To design and validate a ribozyme targeting human caspase-3.
- To assess the efficacy of the ribozyme in down-regulating caspase-3 expression in a lung carcinoma cell line.
Main Methods:
- In vitro cleavage assays to test ribozyme activity.
- Transfection of a ribozyme into a drug-resistant human lung carcinoma cell line (DLKP-A5F).
- Analysis of caspase-3 mRNA and protein levels following stable and transient transfection.
Main Results:
- The designed ribozyme demonstrated effective in vitro cleavage activity.
- Successful down-regulation of human caspase-3 mRNA was achieved.
- Significant reduction in human caspase-3 protein levels was observed in transfected cells.
Conclusions:
- A novel ribozyme effectively targets and reduces human caspase-3 expression.
- This ribozyme shows potential as a tool for modulating apoptosis in cancer cells.
- The findings support the use of ribozymes for gene silencing in drug-resistant cancer models.

